Agios Pharmaceuticals, Inc. (FRA:8AP)

Agios Pharmaceuticals Revenue

Agios Pharmaceuticals had revenue of $12.88M USD in the quarter ending September 30, 2025, with 43.69% growth. This brings the company's revenue in the last twelve months to $44.79M, up 36.26% year-over-year. In the year 2024, Agios Pharmaceuticals had annual revenue of $36.50M with 36.07% growth.

• Revenue (ttm): $44.79M
• Revenue Growth: +36.26%
• P/S Ratio: 36.58
• Revenue / Employee: $91.78K
• Employees: 488
• Market Cap: 1.40B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	36.50M	9.68M	36.07%
Dec 31, 2023	26.82M	12.58M	88.36%
Dec 31, 2022	14.24M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	94.39M	51.38M	119.45%
Dec 31, 2017	43.01M	-26.88M	-38.46%
Dec 31, 2016	69.89M	10.77M	18.22%
Dec 31, 2015	59.12M	-6.24M	-9.55%
Dec 31, 2014	65.36M	39.81M	155.82%
Dec 31, 2013	25.55M	442.00K	1.76%
Dec 31, 2012	25.11M	3.27M	14.97%
Dec 31, 2011	21.84M	-	-